Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United StatesDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasmRecruitingPhase 22026-08-24NCT07554521

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
BeOne Medicines76

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Bioresearch Partners Holding Hialeah HospitalHialeahUnited States2
BRCR Coral SpringsCoral SpringsUnited States3
Florida Clinical Trials Group PlantationPlantationUnited States3
Florida Clinical Trials Group TamaracTamaracUnited States3
Gabrail Cancer Center ResearchCantonUnited States2
Helios Clinical ResearchCerritosUnited States4
Los Angeles Cancer NetworkLos AngelesUnited States6
Washington University School of MedicineSt LouisUnited States19